C83.33
Diffuse large B-cell lymphoma, intra-abdominal lymph nodes
Clinical Classification Guidelines
Medical Intelligence & Overview
Diffuse large B-cell lymphoma (DLBCL) is a type of non-Hodgkin lymphoma characterized by rapidly growing cancerous B-cells. When it occurs in intra-abdominal lymph nodes, it can affect areas within the abdomen such as the abdomen's lymphatic tissues, including lymph nodes, spleen, and surrounding structures. This form of lymphoma is considered aggressive but can often respond well to treatment when diagnosed early. Understanding the nature of this condition helps in appreciating the importance of timely medical intervention.
Causes & Symptoms
Clinical Causes: Genetic mutations in B-cells that lead to abnormal growth Immunosuppression due to conditions like HIV/AIDS or post-organ transplantation Infections such as Epstein-Barr virus (EBV) and Helicobacter pylori Exposure to certain chemicals or radiation Age-related factors, with a higher incidence in older adults
Key Symptoms: Swelling or a palpable lump in the abdomen Persistent abdominal pain or discomfort Unexplained weight loss Night sweats and fever Feeling full quickly after eating Fatigue and weakness Gastrointestinal symptoms like nausea or vomiting in some cases
Diagnostic & Treatment
Diagnosis Path: Diagnosis typically involves a combination of clinical examinations and diagnostic tests, including:
Treatment Protocols: Treatment strategies for diffuse large B-cell lymphoma affecting intra-abdominal lymph nodes generally involve:
Clinical Advice & FAQs
Billing Guidance
Is C83.33 a billable ICD-10 code?
Yes, C83.33 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C83.33?
Clinical documentation must specify the nature of Diffuse large B-cell lymphoma, intra-abdominal lymph nodes and any associated comorbidities for accurate reporting.
Cite this Clinical Reference